Global Biopharmaceutical Processing Equipment And Consumable Market Size By Type (Filtration, Chromatography), By Application (Commercial, Research), By Region, And Segment Forecasts, 2023 to 2032

The Global Biopharmaceutical Processing Equipment and Consumable Market was valued at USD 18.9 billion in 2023 and is projected to surpass USD 39.4 billion by 2031, growing at a CAGR of 9.7% during the forecast period from 2023 to 2031. This significant growth is fueled by increasing global demand for biopharmaceuticals, advancements in single-use technologies, and the rising emphasis on process efficiency and contamination control. Biopharmaceutical companies are increasingly investing in modern equipment and consumables to streamline production and meet stringent regulatory standards, making this market pivotal in the evolution of biologic drug manufacturing.

Drivers:

1. Increasing Demand for Biologics:

The surge in biologic drugs, including monoclonal antibodies, vaccines, and recombinant proteins, is driving the demand for advanced processing equipment and consumables. These drugs require highly specialized manufacturing environments, boosting investments in biopharmaceutical production facilities.

2. Technological Advancements in Bioprocessing:

Innovations such as continuous bioprocessing, single-use systems, and automation are revolutionizing biopharmaceutical manufacturing. These advancements improve flexibility, reduce contamination risks, and enhance overall productivity.

3. Expansion of Biopharma Manufacturing Capacity:

Pharmaceutical companies worldwide are expanding their production capabilities to meet growing demand and reduce dependency on third-party contract manufacturers. This expansion is driving the need for scalable and modular biopharmaceutical processing systems.

Restraints:

1. High Capital Investment:

Setting up biopharmaceutical manufacturing infrastructure requires significant investment in advanced equipment, cleanrooms, and consumables, posing a financial challenge for small and mid-sized companies.

2. Supply Chain Disruptions and Raw Material Shortages:

The biopharmaceutical industry is highly sensitive to supply chain disruptions. Shortages or delays in critical components, such as filters, tubing, or single-use bags, can adversely affect production timelines.

Opportunity:

1. Growth in Biosimilars and Personalized Medicine:

As biosimilars gain traction and personalized therapies become more prevalent, the need for flexible, scalable, and high-quality processing systems grows. Equipment and consumables that support small-batch production offer new growth opportunities.

2. Emerging Markets and Global Expansion:

Rising healthcare investment and pharmaceutical manufacturing expansion in regions like Asia-Pacific and Latin America present lucrative opportunities for market players to cater to new biopharma facilities.

Market by System Type Insights:

The single-use bioprocessing systems segment accounted for the largest market share in 2023. These systems offer greater flexibility, reduced cross-contamination, and lower operational costs, making them increasingly preferred in both R&D and commercial production settings. The stainless-steel bioreactors segment continues to grow steadily, particularly in large-scale manufacturing where reusability and durability are prioritized.

Market by End-use Insights:

The biopharmaceutical companies segment dominated the market in 2023, driven by the ongoing expansion of in-house production capabilities. The contract manufacturing organizations (CMOs) segment is expected to register the fastest growth, fueled by increasing outsourcing trends and the need for cost-effective production solutions.

Market by Regional Insights:

North America led the global market in 2023, driven by a robust biopharmaceutical industry, well-established regulatory frameworks, and significant R&D investments. Asia-Pacific is anticipated to witness the highest growth during the forecast period due to increased pharmaceutical investments, favorable government policies, and the rising demand for biologics in countries like China, India, and South Korea.

Competitive Scenario:

Key players in the Global Biopharmaceutical Processing Equipment and Consumable Market include Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, Merck KGaA, GE Healthcare, Eppendorf AG, Parker Hannifin Corporation, Repligen Corporation, 3M Company, and Avantor, Inc. These companies are focusing on strategic collaborations, capacity expansions, and product innovations to gain competitive advantage.

Scope of Work – Global Biopharmaceutical Processing Equipment and Consumable Market

Report Metric Details

Market Size (2023) USD 18.9 Billion

Projected Market Size (2031) USD 39.4 Billion

CAGR (2023-2031) 9.7%

Market Segments By System Type (Single-use Systems, Reusable Systems), By End-Use (Biopharma Companies, CMOs, Research Institutes), By Region

Growth Drivers Rising demand for biologics, Technological advancements, Expansion of manufacturing facilities

Opportunities Expansion in emerging markets, Growth of biosimilars, Personalized medicine trend

Key Market Developments:

January 2024: Sartorius launched a new range of single-use bioreactor systems with enhanced scalability for pilot and commercial applications.

November 2023: Thermo Fisher Scientific announced the expansion of its manufacturing facility in Singapore to support increased global demand for consumables.

August 2023: Danaher Corporation acquired a bioprocessing equipment provider to strengthen its end-to-end biopharma solutions portfolio.

May 2023: Merck KGaA unveiled a new filtration and chromatography platform tailored for continuous bioprocessing workflows.

FAQs:

1) What is the current market size of the Global Biopharmaceutical Processing Equipment and Consumable Market?

The market was valued at USD 18.9 billion in 2023.

2) What is the major growth driver of the Global Biopharmaceutical Processing Equipment and Consumable Market?

The major growth driver is the increasing demand for biologics and the advancement of single-use bioprocessing technologies.

3) Which is the largest region during the forecast period in the Global Biopharmaceutical Processing Equipment and Consumable Market?

North America holds the largest market share due to its strong biopharmaceutical infrastructure and innovation ecosystem.

4) Which segment accounted for the largest market share in the Global Biopharmaceutical Processing Equipment and Consumable Market?

The single-use systems segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Biopharmaceutical Processing Equipment and Consumable Market?

Key players include Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, Merck KGaA, and GE Healthcare.